10 of Wall Street’s Outperformers

Page 9 of 9

1. Clover Health Investments, Corp. (NASDAQ:CLOV)

Clover Health saw its share prices soar by 40.96 percent week-on-week as investors took heart from a “buy” recommendation from an investment firm.

In a market note, Zacks Research upgraded Clover Health Investments, Corp. (NASDAQ:CLOV) to “buy,” following an upward trend in earnings estimates—one of the most powerful forces impacting stock prices.”

“For the fiscal year ending December 2025, [Clover Health Investments, Corp. (NASDAQ:CLOV)] is expected to earn $0.10 per share, which is unchanged compared with the year-ago reported number. Analysts have been steadily raising their estimates for Clover Health Investments. Over the past three months, the Zacks Consensus Estimate for the company has increased 25 percent,” the note said.

Based on its historical reporting dates, Clover Health Investments, Corp. (NASDAQ:CLOV) is expected to release the results of its third quarter financial and operating highlights on November 6, 2025.

While we acknowledge the potential of CLOV to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CLOV and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.

Page 9 of 9